Evidence map›Paper›PMID 39002525›Full record

ArticleSchizophrenia research2024

Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.

Silvia Corbera, Bruce E Wexler, Morris D Bell, Brian Pittman, Kevin Pelphrey, Godfrey Pearlson, Michal Assaf

Abstract read
In one paragraph

Article in Schizophrenia research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. [From clinical high risk for psychosis to autism spectrum disorder: navigating the challenges of differential diagnosis-A case report].Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Silvia CorberaCentral Connecticut State University, Department of Psychological Science, New Britain, CT, USA. Electronic address: silviac@ccsu.edu.
Bruce E WexlerYale University, School of Medicine, Department of Psychiatry, New Haven, CT, USA.
Morris D BellYale University, School of Medicine, Department of Psychiatry, New Haven, CT, USA.
Brian PittmanYale University, School of Medicine, Department of Psychiatry, New Haven, CT, USA.
Kevin PelphreyUniversity of Virginia, Department of Neurology, Charlottesville, VA, USA.
Godfrey PearlsonYale University, School of Medicine, Department of Psychiatry, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.
Michal AssafYale University, School of Medicine, Department of Psychiatry, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Neural Architecture of Social Emotional Processing and Regulation in Autism Spectrum Disorder: A Dynamic Connectivity PerspectiveR01MH119069 · NIMH · HARTFORD HOSPITAL · PI ASSAF, MICHAL · 2019 to 2023
$3.6M
The Social Brain in Schizophrenia and Autism Spectrum DisordersR01MH095888 · NIMH · HARTFORD HOSPITAL · PI ASSAF, MICHAL · 2012 to 2016
$2.6M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH095888NIMH NIH HHS R01 MH119069
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) and schizophrenia (SZ) share traits, especially in social skills and negative symptoms, and to a lesser degree positive symptoms. Differential diagnosis can be challenging and discerning expressive and experiential negative symptoms may provide knowledge with potential diagnostic and functional relevance that can guide treatment. Two exploratory factor analyses (EFA) were conducted to reveal the underlying dimensions of negative and positive symptoms using the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Positive Symptoms & Negative Symptoms (SAPS/SANS) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G). Three factors emerged from the negative symptom EFA (70.5 % variance): NF1) Expressive Negative; NF2) Experiential Negative; and NF3) Preoccupation, Absorption & Expressive Affective Flattening. Three positive factors emerged (68.6 % variance): PF1) Hallucinations-Delusions; PF2) Grandiosity; and PF3) Thought Disorder-ADOS positive Symptoms. SZ showed higher PF1 scores, and ASD had higher PF3 scores. No differences between groups were observed in the negative factors. Across groups, all negative factors were inversely associated with quality of life. Only NF1 and NF2 and PF1 were detrimentally related to social functioning. A discriminant function analysis using all factors classified correctly 84.4 % of participants, with PF1, NF1 followed by NF2 being the best predictors of diagnosis. Expressive negative followed by Experiential negative symptoms are of diagnostic value independent of and beyond SZ-related positive symptoms and are related with detrimental functioning. Findings confirm the need to distinctively target negative symptoms, and specific SZ-related and ASD-related positive symptoms, and especially the use of several assessment tools for diagnostic classification.

Indexed as

Autism Spectrum DisorderPsychiatric Status Rating ScalesSchizophreniaSchizophrenic PsychologyAdultDiagnosis, DifferentialFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedQuality of LifeYoung AdultFactor analysisQuality of lifeSocial functioning

Identifiers

PMID39002525
PMCPMC11384336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.